Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
AGN
Allergan plc
AGN
|
+$603M |
| 3 |
Meta Platforms (Facebook)
META
|
+$459M |
| 4 |
Alibaba
BABA
|
+$361M |
| 5 |
Amazon
AMZN
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$2.49B |
| 2 |
Qualcomm
QCOM
|
+$424M |
| 3 |
Oracle
ORCL
|
+$369M |
| 4 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$351M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$311M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.16% |
| 2 | Financials | 5.29% |
| 3 | Healthcare | 5.26% |
| 4 | Consumer Discretionary | 4.52% |
| 5 | Communication Services | 3.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Starbucks
SBUX
$118B
| $152M | 0.12% |
1,724,024
-345,208
| -17% | -$32M |
|
152
PUT
Micron Technology
MU
$1.04T
| $152M | 0.12% |
3,541,300
-4,028,200
| -53% | -$182M |
|
153
MetLife
MET
$61B
| $150M | 0.12% |
3,185,624
-1,247,847
| -28% | -$59.5M |
|
154
Goldman Sachs
GS
$313B
| $150M | 0.12% |
722,869
-244,556
| -25% | -$51.1M |
|
155
iShares Russell 2000 Growth ETF
IWO
$14.5B
| $149M | 0.12% |
773,814
+397,259
| +105% | +$78.8M |
|
156
Kimberly-Clark
KMB
$36.4B
| $148M | 0.12% |
1,043,089
+675,336
| +184% | +$92.8M |
|
157
Ford
F
$57.3B
| $146M | 0.12% |
15,895,005
-1,315,325
| -8% | -$12.5M |
|
158
CALL
iShares MSCI Brazil ETF
EWZ
$9.05B
| $145M | 0.12% |
3,446,600
+2,738,500
| +387% | +$118M |
|
159
CALL
iShares MSCI EAFE ETF
EFA
$76.4B
| $145M | 0.12% |
2,225,000
-2,197,900
| -50% | -$142M |
|
160
Church & Dwight Co
CHD
$23.1B
| $144M | 0.11% |
1,919,365
+1,518,196
| +378% | +$115M |
|
161
CALL
Home Depot
HD
$332B
| $144M | 0.11% |
619,600
+127,600
| +26% | +$27.9M |
|
162
IQVIA
IQV
$34.7B
| $143M | 0.11% |
957,563
+479,267
| +100% | +$74.6M |
|
163
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.42B
| $143M | 0.11% |
1,598,725
-718,750
| -31% | -$67.7M |
|
|
AABA
164
DELISTED
Altaba Inc
AABA
| $143M | 0.11% |
7,339,330
+5,179,765
| +240% | +$342M |
|
165
Enterprise Products Partners
EPD
$83.8B
| $142M | 0.11% |
4,968,192
+4,084,966
| +463% | +$119M |
|
166
Accenture
ACN
$89.9B
| $141M | 0.11% |
733,891
-75,416
| -9% | -$14.6M |
|
|
167
CALL
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.42B
| $141M | 0.11% |
1,571,000
+1,171,300
| +293% | +$110M |
|
|
WBC
168
DELISTED
WABCO HOLDINGS INC.
WBC
| $140M | 0.11% |
1,049,394
+37,559
| +4% | +$5M |
|
169
Intuitive Surgical
ISRG
$121B
| $138M | 0.11% |
769,236
+445,797
| +138% | +$77.1M |
|
170
Walmart Inc
WMT
$871B
| $137M | 0.11% |
3,467,211
-2,356,107
| -40% | -$88.9M |
|
171
Coca-Cola
KO
$354B
| $137M | 0.11% |
2,512,877
-1,030,579
| -29% | -$55.2M |
|
|
DIVC
172
DELISTED
C-Tracks Exchange Traded Notes Miller/Howard Strategic Dividend Reinvestor Due September 16, 2024
DIVC
| $137M | 0.11% |
3,975,951
| – | – |
|
|
CELG
173
PUT
DELISTED
Celgene Corp
CELG
| $136M | 0.11% |
1,372,000
+250,800
| +22% | +$23.8M |
|
174
Medtronic
MDT
$107B
| $135M | 0.11% |
1,247,019
-781,076
| -39% | -$81.5M |
|
175
Colgate-Palmolive
CL
$72.6B
| $135M | 0.11% |
1,830,616
+440,186
| +32% | +$31.9M |
|
Similar funds
Citigroup's Q3 2019 Portfolio in Review
As of Q3 2019, Citigroup held 8,008 positions worth $126B, up 1.9% from $124B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup's Q3 2019 filing shows 182 new, 3,096 increased, 3,760 reduced and 268 closed positions. Its largest new stake was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M. The largest sale was iShares Russell 1000 Value ETF, an estimated $2.49B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.8% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q3 2019 buy was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $1.26B increase.
- Citigroup's biggest Q3 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $2.49B.
- Citigroup fully exited Red Hat Inc in Q3 2019, selling an estimated $311M.
- Citigroup's ten largest holdings make up 21% of its $126B portfolio in Q3 2019.
- Citigroup opened 182 new positions and closed 268 in Q3 2019.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $126B.
Based on Citigroup's 13F filing for Q3 2019, filed 8 Nov 2019.